• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP MITROFLOW 12A; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP MITROFLOW 12A; TISSUE HEART VALVE Back to Search Results
Model Number 12A19
Device Problem Gradient Increase (1270)
Patient Problem Valvular Stenosis (2697)
Event Type  Injury  
Manufacturer Narrative
According to the physician, the patient¿s medication (prednisolone) could contribute to this early valve dysfunction, because this medicine is a strong anti-inflammatory agent and thrombosis is known as one of adverse effects with a long-term administration.However, at this point there is no indication of valve failure specifically due to thrombosis, so the relationship of the event to the patient's medication remains unknown.The manufacturer was notified that further information, such as the patient's medical history, is not available for this case.Device not explanted.
 
Event Description
On (b)(6) 2014, a mitroflow valve was implanted due to stenosis and increased pressure gradient.The patient also exhibited aortitis.A bentall operation was performed, and the mitroflow valve was implanted.In (b)(6) 2017, mitroflow valve stenosis was reported to have rapidly progressed within the previous 6 months, and increased pressure gradient was observed.A valve-in-valve procedure was performed.No further information was available at the time of reporting this event.
 
Event Description
Manufacturer received additional information on (b)(6) 2018 that poor leaflet movement was observed in one leaflet on echo observation.The patient had been taking steroid drug, but it is unknown if this drug could contribute to aortic stenosis.This patient fainted twice, but the detail cause is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITROFLOW 12A
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc V5J5M 1
CA  V5J5M1
MDR Report Key7197210
MDR Text Key97439152
Report Number3004478276-2018-00115
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000016
UDI-Public(01)00896208000016(240)12A19(17)190630
Combination Product (y/n)N
PMA/PMN Number
P060038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 02/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date06/30/2019
Device Model Number12A19
Device Catalogue Number12A19
Was Device Available for Evaluation? No
Date Manufacturer Received02/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-